利奈唑胺治疗广泛耐药结核病：回顾性数据得到实验证据的证实。 - Suppr

Linezolid to treat extensively drug-resistant TB: retrospective data are confirmed by experimental evidence.

作者信息

Sotgiu Giovanni, Centis Rosella, D'Ambrosio Lia, Spanevello Antonio, Migliori Giovanni Battista

出版信息

Eur Respir J. 2013 Jul;42(1):288-90. doi: 10.1183/09031936.00191712.

DOI:10.1183/09031936.00191712

PMID:23813314

Abstract

摘要

相似文献

Linezolid to treat extensively drug-resistant TB: retrospective data are confirmed by experimental evidence.

Eur Respir J. 2013 Jul;42(1):288-90. doi: 10.1183/09031936.00191712.

Low minimal inhibitory concentrations of linezolid against multidrug-resistant tuberculosis strains.

Eur Respir J. 2015 Jan;45(1):287-9. doi: 10.1183/09031936.00135014.

Low minimal inhibitory concentrations of linezolid against multidrug-resistant tuberculosis strains.

Eur Respir J. 2015 Jan;45(1):285-7. doi: 10.1183/09031936.00084614.

Comment on: Daily 300 mg dose of linezolid for the treatment of intractable multidrug-resistant and extensively drug-resistant tuberculosis.

J Antimicrob Chemother. 2009 Nov;64(5):1119; author reply 1119-20. doi: 10.1093/jac/dkp291. Epub 2009 Aug 8.

Daily 300 mg dose of linezolid for the treatment of intractable multidrug-resistant and extensively drug-resistant tuberculosis--authors' response.

J Antimicrob Chemother. 2009 Nov;64(5):1119-20. doi: 10.1093/jac/dkp344. Epub 2009 Sep 10.

Linezolid for Treating Tuberculosis: A Delicate Balancing Act.

EBioMedicine. 2015 Oct 21;2(11):1568-9. doi: 10.1016/j.ebiom.2015.10.014. eCollection 2015 Nov.

Treatment of multidrug-resistant and extensively drug-resistant tuberculosis in adolescent patients.

Pediatr Infect Dis J. 2014 Jun;33(6):657-9. doi: 10.1097/INF.0000000000000341.

Linezolid-containing regimens for the treatment of drug-resistant tuberculosis in South African children.

Int J Tuberc Lung Dis. 2012 Dec;16(12):1588-93. doi: 10.5588/ijtld.12.0322. Epub 2012 Oct 2.

Linezolid for extensively drug-resistant tuberculosis.

N Engl J Med. 2013 Jan 17;368(3):291. doi: 10.1056/NEJMc1214183.

Linezolid for extensively drug-resistant tuberculosis.

N Engl J Med. 2013 Jan 17;368(3):290-1. doi: 10.1056/NEJMc1214183.

引用本文的文献

Linezolid Pharmacokinetic-Anemia Modeling in Children With Rifampicin-Resistant Tuberculosis.

Clin Infect Dis. 2024 Dec 17;79(6):1495-1502. doi: 10.1093/cid/ciae497.

Meropenem-vaborbactam restoration of first-line drug efficacy and comparison of meropenem-vaborbactam-moxifloxacin versus BPaL MDR-TB regimen.

Int J Antimicrob Agents. 2023 Dec;62(6):106968. doi: 10.1016/j.ijantimicag.2023.106968. Epub 2023 Sep 17.

Low-Dose Linezolid for Treatment of Patients With Multidrug-Resistant Tuberculosis.

Open Forum Infect Dis. 2022 Oct 5;9(12):ofac500. doi: 10.1093/ofid/ofac500. eCollection 2022 Dec.

Treatment Outcomes Among Pediatric Patients With Highly Drug-Resistant Tuberculosis: The Role of New and Repurposed Second-Line Tuberculosis Drugs.

J Pediatric Infect Dis Soc. 2021 Apr 30;10(4):457-467. doi: 10.1093/jpids/piaa139.

Promising Lead Compounds in the Development of Potential Clinical Drug Candidate for Drug-Resistant Tuberculosis.

Molecules. 2020 Dec 2;25(23):5685. doi: 10.3390/molecules25235685.

Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline.

Am J Respir Crit Care Med. 2019 Nov 15;200(10):e93-e142. doi: 10.1164/rccm.201909-1874ST.

Pharmacokinetics, optimal dosing, and safety of linezolid in children with multidrug-resistant tuberculosis: Combined data from two prospective observational studies.

PLoS Med. 2019 Apr 30;16(4):e1002789. doi: 10.1371/journal.pmed.1002789. eCollection 2019 Apr.

Genetic polymorphisms of long noncoding RNA RP11-37B2.1 associate with susceptibility of tuberculosis and adverse events of antituberculosis drugs in west China.

J Clin Lab Anal. 2019 Jun;33(5):e22880. doi: 10.1002/jcla.22880. Epub 2019 Mar 28.

The Sterilizing Effect of Intermittent Tedizolid for Pulmonary Tuberculosis.

Clin Infect Dis. 2018 Nov 28;67(suppl_3):S336-S341. doi: 10.1093/cid/ciy626.

Tuberculosis elimination: where are we now?

Eur Respir Rev. 2018 Jun 13;27(148). doi: 10.1183/16000617.0035-2018. Print 2018 Jun 30.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Linezolid to treat extensively drug-resistant TB: retrospective data are confirmed by experimental evidence.

作者信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献